AfterQuery | $30,000,000 | (Apr 10, 2026)
Plume (YC S24) | $3,900,000 | (Apr 10, 2026)
Rork | $15,000,000 | (Apr 10, 2026)
Certified by Founder
Lodge
Novoron Bioscience
start up
United States
- San Diego, California
- 16/11/2021
- Seed
- $3,000,000
Novoron Bioscience is a biotechnology company that develops pharmaceutical therapies to regenerate nerves of the central nervous system (CNS). We have received multiple Phase 1 grants from the National Institutes of Health (NIH) in order to pursue our passion: To develop our ground-breaking discovery into therapies that promote recovery for patients suffering from conditions resulting from a damaged CNS.
- Industry Biotechnology Research
- Website https://novoron.com/
- LinkedIn https://www.linkedin.com/company/novoron-bioscience/
Related People
Travis StilesFounder
United States -
San Diego, California,
Scientist turned entrepreneur. Founder Novoron Bioscience developing neuroregenerative therapies. Public speaker passionate about overcoming barriers to innovation and embracing the complexity of human disease towards improving the human condition.
Haast | $12,000,000 | (Apr 10, 2026)
CareGlance Srl | $4,092,182 | (Apr 10, 2026)
Elorian AI | $55,000,000 | (Apr 10, 2026)
TeiaCare & Ancelia: AI for Care Homes | $8,184,645 | (Apr 10, 2026)
Sigma Automate | $2,750,000 | (Apr 10, 2026)
Felix(1) | $1,700,000 | (Apr 10, 2026)
Aria Networks, Inc. | $125,000,000 | (Apr 9, 2026)
Trent AI | $13,000,000 | (Apr 9, 2026)
Golden Analytics | $7,000,000 | (Apr 9, 2026)